Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. (2013)

First Author: Jovanovic JV
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 23860450

Publication URI:

Type: Journal Article/Review

Volume: 27

Parent Publication: Leukemia

Issue: 10

ISSN: 0887-6924